Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
Like
Facebook
Tweet
The 'New' Wave: Anti-Interleukins Are Here
Saturday, July 22, 2023
9:55 AM – 10:15 AM
.
Speaker(s)
Gil Y. Melmed, MD, MS, FACG, AGAF
Cedars-Sinai Medical Center
Los Angeles, California
Learning Objectives:
Summarize the potential role of IL inhibitors in the treatment of IBD
Evaluate key efficacy and safety data for interleukin (IL)-12/23 and IL-23p19 inhibitors for the management of IBD
Incorporate shared decision-making, consistent communication, and consideration of the patient perspective into the care strategy of patients with IBD